Replies to post #83781 on Cytodyn Inc (CYDY)

[bobshmob]

I would expect the unresolved ECMO cases to skew toward survival because the fatal cases tend to progress surprisingly quickly once ARDS sets in.

There's another study from WVU that shows ballpark similar survival numbers in 32 patients (5/15 survive, 17 unresolved) but again with a large number of unresolved cases and a mishmash of treatments.

I don't think we can say what the expected survival rate is for ECMO patients in general because we don't have anything approaching a good sample, but the anecdotes indicate that survival rates may be pretty good. [Keep in mind these >1400 patients are all ECMO + remdesivir or HCQ or tocilizumab or other treatment.]